Save
Issue Information
ISTH Academy, Faculty / Presenters, 4151195
The intricate allostery in factor VIIa: triggering the trigger
ISTH Academy, Ole H. Olsen, 4151196
Hematological causes of acute ischemic stroke in younger individuals
ISTH Academy, Faculty / Presenters, 4151197
Déjà vu all over again: a recurrent flaw in anticoagulant study design
ISTH Academy, Faculty / Presenters, 4151198
Moving medical management to community care: time to consider thromboprophylaxis for “ambulatory” patients?
ISTH Academy, Alexander Cohen, 4151199
Thrombocytopenia in pediatrics: bridging the gap from discovery to management—a long way to go
ISTH Academy, , 4151200
Commentary on “Antiproliferative agent attenuates post-thrombotic vein wall remodeling in murine and human subjects”
ISTH Academy, Peter Henke, 4151201
Circulating tumor DNA: the dawn of new, clinically scalable biomarkers for thromboembolism
ISTH Academy, , 4151203
New antiplatelet approach: inhibiting Pim kinase to reduce constitutive surface expression of thromboxane A receptor
ISTH Academy, Faculty / Presenters, 4151204
Management of antithrombotic therapy in patients undergoing dental procedures
ISTH Academy, Behnood Bikdeli, 4151205
Invasive procedures and surgery following etranacogene dezaparvovec gene therapy in people with hemophilia B
ISTH Academy, Faculty / Presenters, 4151206
Comprehensive evaluation of anti-emicizumab antibodies in acquired hemophilia A: a detailed case study and methodological evaluation
ISTH Academy, Johannes Oldenburg, 4151207
Phosphatidylserine-blocking nanoparticles inhibit thrombosis without increased bleeding in mice
ISTH Academy, Lawrence Goldfinger, 4151209
Alterations in visible light exposure modulate platelet function and regulate thrombus formation
ISTH Academy, Faculty / Presenters, 4151210
Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolism
ISTH Academy, Sameer Parikh, 4151212
Erythrophagocytosis-induced ferroptosis contributes to pulmonary microvascular thrombosis and thrombotic vascular remodeling in pulmonary arterial hypertension
ISTH Academy, , 4151213
Loss of function in protein Z (PROZ) is associated with increased risk of ischemic stroke in the UK Biobank
ISTH Academy, Pavan Bendapudi, 4151214
Incidence and risk factors for postthrombotic syndrome in neonates and children in a single-center cohort study
ISTH Academy, Faculty / Presenters, 4151215
Management and outcomes in patients with tumor thrombus: a retrospective cohort study
ISTH Academy, Tzu-Fei Wang, 4151217
Aptamer BT200 is protective against myocardial ischemia-reperfusion injury in mice
ISTH Academy, , 4151219
Association of primary and secondary hemostasis biomarkers with acute ischemic stroke outcome in patients undergoing thrombectomy, with or without thrombolytics: post hoc analysis of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands-NO IV
ISTH Academy, Moniek de Maat, 4151220
Critical role for platelet Ral GTPases in regulating venous thrombosis in mice
ISTH Academy, Alastair Poole, 4151222
Thrombocytopenia developed in intensive care unit for congenital heart disease: incidence, risk factors, and outcomes
ISTH Academy, , 4151224
A novel role for thioredoxin-related transmembrane protein TMX4 in platelet activation and thrombus formation
ISTH Academy, Yi Wu, 4151225
Constitutive surface expression of the thromboxane A2 receptor is Pim kinase-dependent
ISTH Academy, , 4151226
High-dose intravenous immunoglobulin G and usual heparin anticoagulation for urgent cardiac surgery in a patient with severe autoimmune heparin-induced thrombocytopenia
ISTH Academy, Faculty / Presenters, 4151229
Antiproliferative agent attenuates postthrombotic vein wall remodeling in murine and human subjects
ISTH Academy, , 4151230
2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria solid phase–based antiphospholipid antibody domain—collaborative efforts of Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking and ISTH SSC to harmonize enzyme-linked immunosorbent assay and non–enzyme-linked immunosorbent assay antiphospholipid antibody tests: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibod
ISTH Academy, Faculty / Presenters, 4151231
Recommendations for defining disturbed flow as laminar, transitional, or turbulent in assays of hemostasis and thrombosis: communication from the ISTH SSC Subcommittee on Biorheology
ISTH Academy, Faculty / Presenters, 4151232
Annoucements
ISTH Academy, Faculty / Presenters, 4151233
Issue Information
ISTH Academy, Faculty / Presenters, 4151512
The intricate allostery in factor VIIa: triggering the trigger
ISTH Academy, Ole H. Olsen, 4151513
Hematological causes of acute ischemic stroke in younger individuals
ISTH Academy, Faculty / Presenters, 4151514
Moving medical management to community care: time to consider thromboprophylaxis for “ambulatory” patients?
ISTH Academy, Alexander Cohen, 4151516
Thrombocytopenia in pediatrics: bridging the gap from discovery to management—a long way to go
ISTH Academy, , 4151517
Commentary on “Antiproliferative agent attenuates post-thrombotic vein wall remodeling in murine and human subjects”
ISTH Academy, Peter Henke, 4151518
Circulating tumor DNA: the dawn of new, clinically scalable biomarkers for thromboembolism
ISTH Academy, , 4151520
Comprehensive evaluation of anti-emicizumab antibodies in acquired hemophilia A: a detailed case study and methodological evaluation
ISTH Academy, Johannes Oldenburg, 4151524
Same-day emergency care: a retrospective observational study of the incidence and predictors of venous thromboembolism following hospital-based acute ambulatory medical care
ISTH Academy, Faculty / Presenters, 4151525
Phosphatidylserine-blocking nanoparticles inhibit thrombosis without increased bleeding in mice
ISTH Academy, Lawrence Goldfinger, 4151526
Alterations in visible light exposure modulate platelet function and regulate thrombus formation
ISTH Academy, Faculty / Presenters, 4151527
Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolism
ISTH Academy, Sameer Parikh, 4151529
Erythrophagocytosis-induced ferroptosis contributes to pulmonary microvascular thrombosis and thrombotic vascular remodeling in pulmonary arterial hypertension
ISTH Academy, , 4151530
Loss of function in protein Z (PROZ) is associated with increased risk of ischemic stroke in the UK Biobank
ISTH Academy, Pavan Bendapudi, 4151531
Incidence and risk factors for postthrombotic syndrome in neonates and children in a single-center cohort study
ISTH Academy, Faculty / Presenters, 4151532
Use of antithrombotic therapy and the risk of cardiovascular outcomes and bleeding in cancer patients at the end of life: a Danish nationwide cohort study
ISTH Academy, Faculty / Presenters, 4151533
Management and outcomes in patients with tumor thrombus: a retrospective cohort study
ISTH Academy, Tzu-Fei Wang, 4151534
Novel insights into antithrombin deficiency enabled by mass spectrometry-based precision diagnostics
ISTH Academy, Renee Ruhaak, 4151535
Association of primary and secondary hemostasis biomarkers with acute ischemic stroke outcome in patients undergoing thrombectomy, with or without thrombolytics: post hoc analysis of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands-NO IV
ISTH Academy, Moniek de Maat, 4151537
Impact of limited language proficiency on participation in venous thromboembolism research: a retrospective analysis
ISTH Academy, Yan Xu, 4151538
Critical role for platelet Ral GTPases in regulating venous thrombosis in mice
ISTH Academy, Alastair Poole, 4151539
Thrombocytopenia developed in intensive care unit for congenital heart disease: incidence, risk factors, and outcomes
ISTH Academy, , 4151541
A novel role for thioredoxin-related transmembrane protein TMX4 in platelet activation and thrombus formation
ISTH Academy, Yi Wu, 4151542
Constitutive surface expression of the thromboxane A2 receptor is Pim kinase-dependent
ISTH Academy, , 4151543
Genetic engineering of megakaryocytes from blood progenitor cells using messenger RNA lipid nanoparticles
ISTH Academy, Christian Kastrup, 4151544
A gain of function variant in RGS18 candidate for a familial mild bleeding syndrome
ISTH Academy, Marie-Christine Alessi, 4151545
High-dose intravenous immunoglobulin G and usual heparin anticoagulation for urgent cardiac surgery in a patient with severe autoimmune heparin-induced thrombocytopenia
ISTH Academy, Faculty / Presenters, 4151546
2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria solid phase–based antiphospholipid antibody domain—collaborative efforts of Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking and ISTH SSC to harmonize enzyme-linked immunosorbent assay and non–enzyme-linked immunosorbent assay antiphospholipid antibody tests: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibod
ISTH Academy, Faculty / Presenters, 4151548
Recommendations for defining disturbed flow as laminar, transitional, or turbulent in assays of hemostasis and thrombosis: communication from the ISTH SSC Subcommittee on Biorheology
ISTH Academy, Faculty / Presenters, 4151549
Annoucements
ISTH Academy, Faculty / Presenters, 4151550
The detrimental impact of ferritin “normal” ranges on diagnosis of bleeding disorders in women
ISTH Academy, Grace Tang, 4158543
Mini-clusters of postadenovirus VITT
ISTH Academy, Theodore (Ted) Warkentin, 4158544
Venous thromboembolism still leads on maternal death
ISTH Academy, Sue Pavord, 4158545
Thromboprophylaxis in multiple myeloma
ISTH Academy, Laurent Frenzel, 4158546
Transfusion in trauma: empiric or guided therapy?
ISTH Academy, Nicola Curry, 4158547
Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies
ISTH Academy, Ingrid Pabinger, 4158548
Structural bioinformatics for rational drug design
ISTH Academy, Kanin Wichapong, 4158549
Adeno-associated virus-based gene therapy for hemophilia–addressing the gaps
ISTH Academy, , 4158551
Should a history of venous thromboembolism be considered a contraindication for scuba diving?
ISTH Academy, Nicolas Gendron, 4158559
Reduced- versus full-dose anticoagulants for the extended treatment of cancer-associated venous thromboembolism in Thai patients
ISTH Academy, Kochawan Boonyawat, 4158560
Validation of the 5-SNP score for the prediction of venous thromboembolism in a Danish fast-track cohort of 6789 total hip and total knee arthroplasty patients
ISTH Academy, Faculty / Presenters, 4158561
Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trial
ISTH Academy, Runhui Wu, 4158562
Type of D-dimer assay determines the diagnostic yield of computed tomography in patients suspected for pulmonary embolism
ISTH Academy, , 4158563
Management of patients with venous thromboembolism and a high recurrence risk estimated by the Vienna Prediction Model: a prospective cohort study
ISTH Academy, , 4158564
Occurrence and management of thrombosis recurrence and bleeding in low-molecular-weight heparin-treated patients with cancer-associated thrombosis: a French nationwide cohort study
ISTH Academy, , 4158565
Sex-specific cut-off for dilute Russell’s viper venom time lupus anticoagulant test may be of value
ISTH Academy, Faculty / Presenters, 4158568
Health literacy in pediatric thrombosis: a landscape analysis
ISTH Academy, Laura Avila, 4158569
Characterization of bleeding in thrombotic thrombocytopenic purpura in the precaplacizumab era: a retrospective nationwide analysis
ISTH Academy, Faculty / Presenters, 4158570
Prevalence and clinical impact of disseminated intravascular coagulation in acute aortic dissection: a nationwide cohort study
ISTH Academy, Faculty / Presenters, 4158571
A cell-based model to study mechanisms of endothelial-dependent thrombin generation in response to inflammation and its modulation by hydroxychloroquine
ISTH Academy, Faculty / Presenters, 4158574
Plasma microRNA-145-5p as a diagnostic biomarker for acute deep vein thrombosis
ISTH Academy, , 4158575
Characterization of the procoagulant phenotype of amniotic fluid across gestation in rhesus macaques and humans
ISTH Academy, Jamie Lo, 4158578
Transcription factor RUNX1 regulates coagulation factor XIII-A (F13A1): decreased platelet-megakaryocyte F13A1 expression and clot contraction in RUNX1 haplodeficiency
ISTH Academy, A. Koneti Rao, 4158581
Beyond platelet activation: dysregulated lipid metabolism in defining risk and pathophysiology of VITT
ISTH Academy, Faculty / Presenters, 4158582
Carbon dioxide alleviates platelet storage lesions via stimulating fatty acid metabolism and reducing platelet glucose consumption
ISTH Academy, Wen Yin, 4158583
Measurement of factor XIII for the diagnosis and management of deficiencies: insights from a retrospective review of 10 years of data on consecutive samples and patients
ISTH Academy, Catherine Hayward, 4158584
Silencing of the von Willebrand factor gene in proatherothrombotic APOE∗3-Leiden.CETP transgenic mice
ISTH Academy, Bart van Vlijmen, 4158586
Intrinsic pathway activation in patients with antiphospholipid syndrome and healthy controls
ISTH Academy, Thijs van Mens, 4158587
Relevance of anti–platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemic
ISTH Academy, , 4158588
Altered clot structure in pregnant women who will develop postpartum hemorrhage
ISTH Academy, Faculty / Presenters, 4158596
Immune tolerance induction for inhibitor eradication in nonsevere hemophilia A: a case series
ISTH Academy, Faculty / Presenters, 4158597
Acquired factor V inhibitor in a case of pediatric venous thrombosis
ISTH Academy, Faculty / Presenters, 4158598
Prophylactic use of recombinant ADAMTS-13 during pregnancy for congenital thrombotic thrombocytopenic purpura
ISTH Academy, , 4158600
Type of D-dimer assay determines the diagnostic yield of computed tomography in patients suspected for pulmonary embolism
ISTH Academy, , 4176032
Management of patients with venous thromboembolism and a high recurrence risk estimated by the Vienna Prediction Model: a prospective cohort study
ISTH Academy, , 4176033
Investigating tissue factor pathway inhibitor and other protease and protease inhibitors and their association with major adverse aortic events in patients with abdominal aortic aneurysm
ISTH Academy, Mohammad Qadura, 4176035
A cell-based model to study mechanisms of endothelial-dependent thrombin generation in response to inflammation and its modulation by hydroxychloroquine
ISTH Academy, Faculty / Presenters, 4176043
Histologic evidence of neutrophil extracellular traps and fibrin(ogen) deposition in liver biopsies from patients with inflammatory liver disease
ISTH Academy, Faculty / Presenters, 4176045
Comparative analyses of the hemostatic efficacy and surgical device performance of powdered oxidized regenerated cellulose and starch-based powder formulations
ISTH Academy, , 4176046
Characterization of the procoagulant phenotype of amniotic fluid across gestation in rhesus macaques and humans
ISTH Academy, Jamie Lo, 4176047

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings